AI
Saturday, January 14, 2023 4:51:01 PM
Thanks for the reply.
No problem—it sounds like you would prefer a completely different trial from the P3. Take a look at the combo trial! It has a great placebo design that I bet you will love:
The UCLA combo study deserves more publicity and many people are unaware of its interim survival data.
For those who might not have heard:
Aside from the well-publicized P3, there is another clinical study for murcidencel + pembrolizumab specifically for rGBM that has reached its midpoint with interim survival data. This study does not involve any chemo or radiation. OS has not been reached yet because patients are alive. This trial is using an internal placebo control group who are all receiving murcidencel—only Keytruda in combo is being investigated.
https://clinicaltrials.gov/ct2/show/NCT04201873
https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter
https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/
No problem—it sounds like you would prefer a completely different trial from the P3. Take a look at the combo trial! It has a great placebo design that I bet you will love:
The UCLA combo study deserves more publicity and many people are unaware of its interim survival data.
For those who might not have heard:
Aside from the well-publicized P3, there is another clinical study for murcidencel + pembrolizumab specifically for rGBM that has reached its midpoint with interim survival data. This study does not involve any chemo or radiation. OS has not been reached yet because patients are alive. This trial is using an internal placebo control group who are all receiving murcidencel—only Keytruda in combo is being investigated.
https://clinicaltrials.gov/ct2/show/NCT04201873
https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter
https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
